Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Johnson and Johnson
Pharmaceuticals
GSK
AstraZeneca
AbbVie
Roche
Pfizer
Bayer
Sanofi
Topics

Advertisement

Advertisement

Johnson and Johnson

Share

Top Latest Popular

Earlier Today

J&J Says Justices' Denial Backs Tossing Fee Suit At 3rd Circ. Law360 00:17

Yesterday

The International Myeloma Foundation Launches US Myeloma Network to Accelerate Clinical Trials, Expand Access, and Improve Patient Care PR Newswire (Press Release) 13:46 Thu, 22 Oct

Johnson & Johnson Reports First Real-World Varipulse Pro Platform Data and 12-Month Omnypulse Platform Outcomes for Atrial Fibrillation Treatment at Aphrs 2026 Business Wire (Press Release) 12:47 Thu, 22 Oct

Advertisement

Advertisement

Wednesday

Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 The Motley Fool 15:08 Wed, 21 Oct

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now? Zacks 15:06 Wed, 21 Oct

Rapport’s novel oral drug posts Phase II bipolar win Clinical Trials Arena 09:46 Wed, 21 Oct

Tuesday

2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) The Motley Fool 22:10 Tue, 20 Oct

The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services Zacks 14:58 Tue, 20 Oct

CHMP backs TALVEY plus daratumumab for earlier myeloma use PharmaTimes 14:31 Tue, 20 Oct

Stock Watch: J&J’s Pharma Strength Has Its Limits Scrip Pharma Intelligence 12:45 Tue, 20 Oct

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary Ivl Catheter, Cutting Ivl Treatment Time in Half Business Wire (Press Release) 12:45 Tue, 20 Oct

Johnson & Johnson to Showcase the Future of Surgical Intelligence at Abu Dhabi Future Health Summit 2026 Business Wire (Press Release) 07:00 Tue, 20 Oct

Another Talc Trial Opens as J&J Gets Support for $5.8B Settlement Law.com 00:39 Tue, 20 Oct

Monday

Johnson & Johnson announces new data showing Tremfya® (guselkumab) is the only Il-23 to deliver durable fistula remission through 48 weeks in Crohn's disease with perianal fistula PR Newswire (Press Release) 13:01 Mon, 19 Oct

Advertisement

Sunday

JNJ Investors with $100,000 in Losses Have Opportunity to Join Johnson & Johnson Fraud Investigation with SBS Law Business Wire (Press Release) 02:31 Sun, 18 Oct

Saturday

Should You Invest in This Dividend King on the Dip? The Motley Fool 16:20 Sat, 17 Oct

When the Stock Market Gets Dangerous, These 6 Investments Have a History of Holding Up The Motley Fool 12:16 Sat, 17 Oct

Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy. The Motley Fool 11:45 Sat, 17 Oct

Former J&J site cleared for £31m redevelopment BBC 06:22 Sat, 17 Oct

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 02:06 Sat, 17 Oct

In the last month

Asia Deal Watch: Alentis, PinotBio Team Up On Claudin-1 Targeted ADCs For Cancer Scrip Pharma Intelligence 21:43 Fri, 16 Oct

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors The Motley Fool 19:09 Fri, 16 Oct

J&J Says Chmp Recommends Approval Of Talvey Combo In Earlier Line Treatment Of R/R Multiple Myeloma RTT News 13:21 Fri, 16 Oct

US giant’s High Wycombe offices to be demolished as redevelopment plans approved Bucks Free Press 05:05 Fri, 16 Oct

New Earnings Show the Healthcare Sector Has a Pulse ETF Trends 13:30 Thu, 15 Oct

Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts Benzinga 18:50 Wed, 14 Oct

These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results Benzinga 18:08 Wed, 14 Oct

Johnson & Johnson stock slides despite company's projected $100 billion annual sales Fox News 23:22 Tue, 13 Oct

J&J’s Tremfya Rises From Stelara’s Ashes Scrip Pharma Intelligence 21:32 Tue, 13 Oct

Quick spark: J&J Eyes Worst Day Since April 2025 with MedTech Miss Benzinga 19:25 Tue, 13 Oct

Daily Dividend Report: PG,CMC,ACI,JNJ,IP Nasdaq 19:16 Tue, 13 Oct

See Which Recent 13F Filers Hold JNJ But Cooksen Wealth Exited Nasdaq 19:16 Tue, 13 Oct

J&J Spotlights FDA-Approved Surgical Robot Amid $100 Billion Revenue Push PYMNTS.com 18:33 Tue, 13 Oct

Johnson & Johnson Q3 Profit Declines, Lifts FY26 Outlook; Stock Drops RTT News 18:19 Tue, 13 Oct

Here’s How Much Johnson & Johnson Stock Is Expected to Move After Earnings Investopedia 18:13 Tue, 13 Oct

Why Johnson & Johnson Stock Dropped Today The Motley Fool 18:04 Tue, 13 Oct

Johnson & Johnson Stock Falls 5% After Q3 Profit Plunges RTT News 17:19 Tue, 13 Oct

Tremfya rescues J&J’s immunology sales to fuel strong Q3 Pharmaceutical Technology 16:28 Tue, 13 Oct

Johnson & Johnson Warns New Drug Deals Will Hit 2027 Earnings Benzinga 16:11 Tue, 13 Oct

Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest? Zacks 15:38 Tue, 13 Oct

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis